FIGS (NYSE:FIGS – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Saturday.
A number of other research analysts also recently issued reports on FIGS. KeyCorp raised shares of FIGS from a “sector weight” rating to an “overweight” rating and set a $17.00 price objective on the stock in a research report on Friday. Wolfe Research raised shares of FIGS to a “buy” rating in a research note on Wednesday, December 10th. Morgan Stanley increased their price target on shares of FIGS from $7.50 to $8.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 13th. Weiss Ratings restated a “hold (c-)” rating on shares of FIGS in a report on Monday, December 29th. Finally, Barclays lifted their price objective on FIGS from $9.00 to $11.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $12.25.
Get Our Latest Analysis on FIGS
FIGS Price Performance
FIGS (NYSE:FIGS – Get Free Report) last issued its quarterly earnings data on Thursday, February 26th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08. The firm had revenue of $201.90 million for the quarter, compared to analyst estimates of $165.33 million. FIGS had a return on equity of 8.62% and a net margin of 5.43%.The business’s quarterly revenue was up 33.0% compared to the same quarter last year. During the same period last year, the company earned $0.01 EPS. Analysts expect that FIGS will post 0.01 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CFO Sarah Oughtred sold 22,690 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total value of $239,606.40. Following the sale, the chief financial officer directly owned 821,500 shares of the company’s stock, valued at $8,675,040. The trade was a 2.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Heather L. Hasson sold 22,874 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total value of $241,549.44. Following the completion of the sale, the insider owned 1,251,967 shares in the company, valued at $13,220,771.52. The trade was a 1.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 105,813 shares of company stock valued at $1,168,051 over the last quarter. Corporate insiders own 29.44% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in FIGS. Assetmark Inc. purchased a new stake in shares of FIGS in the third quarter worth $35,000. Elevated Capital Advisors LLC purchased a new position in shares of FIGS in the 4th quarter worth about $45,000. Quarry LP boosted its stake in FIGS by 1,876.3% in the 3rd quarter. Quarry LP now owns 7,846 shares of the company’s stock worth $52,000 after purchasing an additional 7,449 shares in the last quarter. Capstone Financial Advisors Inc. bought a new position in FIGS in the 2nd quarter worth about $56,000. Finally, Hudson Bay Capital Management LP purchased a new stake in FIGS during the 2nd quarter valued at about $61,000. Hedge funds and other institutional investors own 92.21% of the company’s stock.
Key FIGS News
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: Q4 earnings beat — FIGS reported $0.10 EPS vs. $0.02 consensus and revenue of $201.9M (up 33% YoY), signaling solid top-line momentum and margin expansion. Article Title
- Positive Sentiment: Aggressive FY2026 revenue guide — management is targeting roughly $694M–$707M (around a $700M target cited publicly), well above Street consensus (~$625.6M), and flagged international expansion and margin improvement as priorities. That guidance materially raises growth expectations. Article Title
- Positive Sentiment: Analyst upgrade — KeyCorp moved FIGS from sector weight to overweight with a $17 price target, providing third‑party validation of the company’s growth trajectory. Article Title
- Neutral Sentiment: Telsey raised its price target from $9 to $15 and set a “market perform” rating — upgrade in target, but PT sits slightly below the current share price. Article Title
- Neutral Sentiment: BTIG reaffirmed a “buy” rating with a $15 target — keeps buy conviction but target is not above the current price, limiting near-term upside from that shop. Article Title
- Neutral Sentiment: Conference call and analyst write-ups published — transcripts and call highlights provide detail on Olympic partnership, international rollout and margin levers for investors doing deeper diligence. Article Title
- Negative Sentiment: Valuation and mixed price-targets risk — FIGS trades with a high P/E and recently hit a 12‑month high, leaving shares vulnerable to profit-taking; several widely cited targets (~$15) sit at or below the current price. Article Title
About FIGS
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Recommended Stories
- Five stocks we like better than FIGS
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- The Biggest IPO Ever… Open to Everyday Folks
- Silver records prices are great. Monthly income is better
- Read this or regret it forever
- Sell this, buy that
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
